Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive for COVID; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (tested positive for COVID) in a 95-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.    No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In June 2022, the patient experienced COVID-19 (tested positive for COVID). At the time of the report, COVID-19 (tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In June 2022, SARS-CoV-2 test: positive positive.     The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication included inhalers. It was reported that the patient had worked with COVID workers for years. It was reported that the patient visited a friend in a place where people were not wearing masks. The patient went to urgent care and tested positive with COVID for the first time ever. The patient had not yet taken Paxlovid. The patient started having symptoms on Monday. The patient wanted to know if after testing positive for COVID, would the patient always test positive or not for COVID-19. The patient went to the urgent care because the inhaler did not work. The patient wanted to take only prednisone. Patient had shown symptoms of cough and head cold after testing positive for COVID-19 and started showing first symptoms on previous Monday. The patient had not lost her sense of taste and smell. The patient asked if the vaccine could help in preventing drastic situations with COVID-19 or not. The patient wanted to know whether after taking Paxlovid for 5 days, would the patient test negative for COVID-19 and whether Paxlovid would stay in the patient's system or not or had any side effects such as developing cancer or HIV or not. The patient wanted to know whether Paxlovid was an antiviral drug or could kill COVID-19 virus or not and whether it would also kill good cells also. Company Comment:  This is a spontaneous case concerning  a  95-year-old, female patient with no reported medical history, who experienced the unexpected non-serious AESI event of Covid-19. The events occurred as reported on unknown date of June 2022 after the unspecified dose of mRNA-1273 COVID 19 Vaccine. Patient tested positive for SARS-CoV-2 test. Patient reported that she went to the urgent care because inhaler did not work. Patient had shown symptoms of cough and head cold after testing positive for Covid-19. No treatment medication was received. Event outcome was unknown. The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report.; Sender's Comments: This is a spontaneous case concerning  a  95-year-old, female patient with no reported medical history, who experienced the unexpected non-serious AESI event of Covid-19. The events occurred as reported on unknown date of June 2022 after the unspecified dose of mRNA-1273 COVID 19 Vaccine. Patient tested positive for SARS-CoV-2 test. Patient reported that she went to the urgent care because inhaler did not work. Patient had shown symptoms of cough and head cold after testing positive for Covid-19. No treatment medication was received. Event outcome was unknown. The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report.